Skip to main content

Advertisement

SpringerLink
Log in

Effects of Antidepressant Treatment on Antiretroviral Regimen Adherence Among Depressed HIV-Infected Patients

  • Original Paper
  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

This study examined whether the relationship between HAART medication adherence and antidepressant treatment varied with HAART regimen complexity. The analysis included 1,192 respondents to the HIV Cost and Service Utilization Study (HCSUS) who were taking HAART. Self-reported past-week HAART adherence, antidepressant use, current mental health status, and an aggregate measure of regimen complexity were used in the analysis. Regression models with interactions between antidepressant treatment of mental health problems, poor emotional well-being or depressive symptoms, and medication complexity were estimated to assess differential associations with adherence. Irrespective of antidepressant treatment, poor mental health status was negatively associated with HAART medication adherence. However, only untreated higher depressive symptoms were strongly associated with maladherence to HAART medication (OR = 0.72 at P < 0.05). Medication complexity was strongly associated with maladherence to HAART medication (OR = 0.96 with P < 0.05) in the model including emotional well-being; and weakly associated with maladherence (OR = 0.97 and P < 0.07) in the model including depressive and/or anxiety symptoms. However, as HAART medication complexity increased, adherence was higher among individuals with poorer mental health but using antidepressants compared to those with better mental health (OR = 1.09 with P < 0.05 in the model including emotional well-being; OR = 1.09 and P < 0.05 in the model including depressive and/or anxiety symptoms), and compared to those with poorer mental health but not using antidepressants (OR = 1.09, P = 0.08 in the model including emotional well-being, and OR = 1.12, P < 0.05 in model including depressive and/or anxiety symptoms). In conclusion, while individuals with poorer mental health generally have poor HAART adherence, their adherence improved with the use of antidepressants as the HAART complexity increased.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bangsberg DR: Less than 95% adherence to nonnucleoside reverse transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Disease 43:939–941, 2006. doi:10.1086/507526

    Article  CAS  Google Scholar 

  2. Osterberg L, Blaschke T: Adherence to medication. New England Journal of Medicine 353:487–497, 2005. doi:10.1056/NEJMra050100

    Article  PubMed  CAS  Google Scholar 

  3. Chesney M: Adherence to HAART regimens. AIDS Patient Care 17:169–177, 2003. doi:10.1089/108729103321619773

    Article  Google Scholar 

  4. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al.: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 133(1):21–30, 2000

    PubMed  CAS  Google Scholar 

  5. Ciesla JA, Roberts JE: Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry 158:725–730, 2001. doi:10.1176/appi.ajp.158.5.725

    Article  PubMed  CAS  Google Scholar 

  6. Mugavero M, Ostermann J, Whetten K, et al.: Barriers to antiretroviral adherence: The importance of depression, abuse, and other traumatic events. AIDS Patient Care STDs 20:418–428, 2006. doi:10.1089/apc.2006.20.418

    Article  PubMed  Google Scholar 

  7. Ammassari A, Antinori A, Aloisi MS, et al.: Depressive symptoms neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics 45:394–402, 2004. doi:10.1176/appi.psy.45.5.394

    Article  PubMed  Google Scholar 

  8. Castaneda AE, Suvisaari J, Marttunen M, Perala J, Saarni SI, et al.: Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity. Journal of Affective Disorders 110(1–2):36–45, 2008. doi:10.1016/j.jad.2007.12.239

    Article  PubMed  CAS  Google Scholar 

  9. Paleacu D, Shutzman A, Giladi N, Herman T, Simon ES, et al.: Effects of pharmacological therapy on gait and congnitive functions in depressed patients. Clinical Neuropharmacology 30(2):63–71, 2007. doi:10.1097/01.wnf.0000240949.41691.95

    Article  PubMed  CAS  Google Scholar 

  10. Austin M-P, Mitchell P, Goodwin GM: Congnitive deficits in depression. British Journal of Psychiatry 178:200–206, 2001. doi:10.1192/bjp.178.3.200

    Article  PubMed  CAS  Google Scholar 

  11. Hinkin CH, Hardy DH, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al.: Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS 18(Suppl 1):S19–S25, 2004. doi:10.1097/00002030-200401001-00004

    PubMed  Google Scholar 

  12. Waldrop-Valverde D, Ownby RL, Wilkie FL, Mack A, Kumar M, et al.: Neurocognitive aspects of medication adherence in HIV-positive injecting drug users. AIDS and Behavior 10(3):287–297, 2006. doi:10.1007/s10461-005-9062-6

    Article  Google Scholar 

  13. Chesney MA: HIV The elusive gold standard: Future perspectives for HIV adherence assessment and intervention. Journal of Acquired Immune Deficiency Syndromes 43(Suppl 1):S149–S155, 2006. doi:10.1097/01.qai.0000243112.91293.26

    Article  Google Scholar 

  14. Friedland GH: HIV medication adherence. The intersection of biomedicatl, behavioral, and social science research and clinical practice. Journal of Acquired Immune Deficiency Syndromes 43(Suppl 1):S3–S9, 2006

    Article  Google Scholar 

  15. Hinkin CH, Castellon SA, Durvasula RS, et al.: Medication adherence among HIV+adults. Neurology 59(12):1944–1950, 2002

    PubMed  CAS  Google Scholar 

  16. Himelhoch S, Medoff DR: Efficacy of antidepressant medication among HIV-positive individuals with depression: A systematic review and meta analysis. AIDS Patient Care and STDs 19(12):813–822, 2005. doi:10.1089/apc.2005.19.813

    Article  PubMed  Google Scholar 

  17. Dalessandro M, Conti CM, Gambi F, Falasca K, Doyle R, et al.: Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. Journal of Clinincal Psychopharmacology 27(1):58–61, 2007. doi:10.1097/JCP.0b013e31802f0dd1

    Article  CAS  Google Scholar 

  18. Walkup J, Wei W, Sambamoorthi U, Crystal S: Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Pyschiatric Quarterly 79:43–53, 2008. doi:10.1007/s11126-007-9055-x

    Article  Google Scholar 

  19. Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, et al.: Effects of depression and selective serotonine reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. Journal of Aquired Immune Deficiency Syndrome 47(3):384–390, 2008

    Article  CAS  Google Scholar 

  20. Martin S, Wolters PL, Calabrese SK, Toledo-Tamula MA, Wood LV, et al.: The antiretroviral regimen complexity index: A novel method of quantifying regimen complexity. Journal of Acquired Immune Deficiency Syndromes 45(5):535–544, 2007. doi:10.1097/QAI.0b013e31811ed1f1

    Article  Google Scholar 

  21. Bozzette SA, Berry SH, Duan N, Frankel MR, Leibowitz AA, Lefkowitz D, et al.: The care of HIV-infected adults in the United States. HIV cost and services utilization study consortium. The New England Journal of Medicine 339(26):1897–1904. doi:10.1056/NEJM199812243392606

    Article  PubMed  CAS  Google Scholar 

  22. Frankel MR, Shapiro MF, Duan N, Morton SC, Berry SH, Brown JA, et al.: National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample. Health Services Research 34(5 Pt 1):969–992, 1999

    PubMed  CAS  Google Scholar 

  23. Shapiro MF, Berk ML, Berry SH, Emmons CA, Athey LA, Hsia DC, et al.: National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study. Health Services Research 34(5 Pt 1):951–968, 1999

    PubMed  CAS  Google Scholar 

  24. United States Department of Agriculture & United States Department of Health and Human Services: In: United States Department of Health and Human Services & United States Department of Agriculture (Eds.), Chapter 9—Alcoholic beverages. Dietary Guidelines for Americans. Washington, DC: US Government Printing Office pp. 43–46, 2005

  25. National Institute of Alcohol Abuse and Alcoholism: NIAAA council approves definition of binge drinking [Electronic Version]. 2004; NIAAA Newsletter, 3. Retrieved October 16, 2007 from http://pubs.niaaa.nih.gov/publications/Newsletter/winter2004/Newsletter_Number3.pdf

  26. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, et al.: The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 13(9):1099–1107, 1999. doi:10.1097/00002030-199906180-00014

    Article  PubMed  CAS  Google Scholar 

  27. Mannheimer S, Friedland G, Matts J, Child C, Chesney M: The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases 34(8):1115–1121, 2002. doi:10.1086/339074

    Article  PubMed  Google Scholar 

  28. Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, et al.: Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence 84(2):188–194, 2006. doi:10.1016/j.drugalcdep.2006.02.003

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Westat, Rockville, MD, USA

    Virender Kumar

  2. Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD, 27850, USA

    William Encinosa

Authors
  1. Virender Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William Encinosa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William Encinosa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, V., Encinosa, W. Effects of Antidepressant Treatment on Antiretroviral Regimen Adherence Among Depressed HIV-Infected Patients. Psychiatr Q 80, 131–141 (2009). https://doi.org/10.1007/s11126-009-9100-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11126-009-9100-z

Keywords

Search

Navigation